Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation.

Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V.

Blood. 2018 Jun 14. pii: blood-2018-03-838672. doi: 10.1182/blood-2018-03-838672. [Epub ahead of print] No abstract available.

PMID:
29903887
2.

High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.

White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V.

Bone Marrow Transplant. 2018 Jun 8. doi: 10.1038/s41409-018-0242-1. [Epub ahead of print] No abstract available.

PMID:
29884854
3.

Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics.

Siddiqi OK, Sanchorawala V, Ruberg FL.

Circ Cardiovasc Imaging. 2018 May;11(5):e007826. doi: 10.1161/CIRCIMAGING.118.007826. No abstract available.

PMID:
29752394
4.

Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients.

Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K.

Transfus Apher Sci. 2018 Apr 26. pii: S1473-0502(18)30145-9. doi: 10.1016/j.transci.2018.04.025. [Epub ahead of print]

PMID:
29731423
5.

Once AL amyloidosis: not always AL amyloidosis.

Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V.

Amyloid. 2018 Mar 8:1-2. doi: 10.1080/13506129.2018.1449104. [Epub ahead of print] No abstract available.

PMID:
29516761
6.

Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Havasi A, Doros G, Sanchorawala V.

Am J Hematol. 2018 May;93(5):E129-E132. doi: 10.1002/ajh.25066. Epub 2018 Feb 24. No abstract available.

PMID:
29430701
7.

Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).

Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S.

Amyloid. 2018 Mar;25(1):62-67. doi: 10.1080/13506129.2018.1436048. Epub 2018 Feb 9.

PMID:
29424556
8.

Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis.

Hari P, Lin HM, Asche CV, Ren J, Yong C, Luptakova K, Faller DV, Sanchorawala V.

Amyloid. 2018 Mar;25(1):1-7. doi: 10.1080/13506129.2017.1411796. Epub 2018 Jan 5.

PMID:
29303358
9.

Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples.

White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS.

Patient Relat Outcome Meas. 2017 Dec 7;8:157-167. doi: 10.2147/PROM.S146849. eCollection 2017.

10.

Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection
.

Ding Y, Francis J, Gautam A, Pelletier L, Sanchorawala V, Quillen K.

Clin Nephrol. 2018 Apr;89(4):252-259. doi: 10.5414/CN109278.

PMID:
29208204
11.

High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.

Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V.

Biol Blood Marrow Transplant. 2018 Jan;24(1):127-132. doi: 10.1016/j.bbmt.2017.08.031. Epub 2017 Sep 1.

PMID:
28865972
12.

A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.

Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, Skinner M.

Br J Haematol. 2017 Nov;179(3):461-470. doi: 10.1111/bjh.14889. Epub 2017 Aug 29.

13.

Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation.

Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V.

Blood. 2017 Sep 14;130(11):1383-1386. doi: 10.1182/blood-2017-06-788729. Epub 2017 Jul 11. No abstract available.

PMID:
28698204
14.

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.

Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, Dispenzieri A, Jaccard A, Schönland SO, Berg D, Yang H, Gupta N, Hui AM, Comenzo RL, Merlini G.

Blood. 2017 Aug 3;130(5):597-605. doi: 10.1182/blood-2017-03-771220. Epub 2017 May 26.

PMID:
28550039
15.

Transbronchial biopsies safely diagnose amyloid lung disease.

Govender P, Keyes CM, Hankinson EA, O'Hara CJ, Sanchorawala V, Berk JL.

Amyloid. 2017 Mar;24(1):37-41. doi: 10.1080/13506129.2017.1301917. Epub 2017 Apr 10.

PMID:
28393574
16.

The six-minute walk test in patients with AL amyloidosis: a single centre case series.

Pulido V, Doros G, Berk JL, Sanchorawala V.

Br J Haematol. 2017 May;177(3):388-394. doi: 10.1111/bjh.14586. Epub 2017 Mar 24.

PMID:
28340285
17.

A Woman in Her 40s With Headache and New-Onset Seizures.

Graham MS, Pudusseri A, Helgager J, Narendra DP, De Girolami U, Pinkus GS, Sanchorawala V, Miyawaki E.

JAMA Neurol. 2017 Apr 1;74(4):476-480. doi: 10.1001/jamaneurol.2016.2961.

PMID:
28241235
18.

Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.

Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1057-1064. doi: 10.1093/ehjci/jew298.

PMID:
27965280
19.

Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.

Uwumugambi NA, Sanchorawala V, Shelton AC, Stern L, Gordon CE.

Am J Kidney Dis. 2017 Feb;69(2):317-319. doi: 10.1053/j.ajkd.2016.07.037. Epub 2016 Oct 22.

PMID:
27780577
20.

Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients.

Shu J, Lo S, Phillips M, Sun F, Seldin DC, Berenbaum I, Berk JL, Sanchorawala V.

Amyloid. 2016 Sep;23(3):188-193. Epub 2016 Jul 27.

PMID:
27460276

Supplemental Content

Loading ...
Support Center